Beike Biotechnology Co. Ltd., ( http://www.beikebiotech.com ) a all-around baton in axis corpuscle analysis and analysis through evidence-based medicine, appear today it has active eight abstracted alternate cooperation agreements with some of China and the world's a lot of outstanding axis corpuscle analysis organizations. As allotment of the agreements, Beike has aswell accustomed a "Stem Cell Expert Advisory Committee" and a abstracted "Data and Safety Monitoring Board (DSMB)" to baby-sit approaching Beike-sponsored research.
The eight accords, initially discussed at the afresh completed 2008 China Stem Cell Technology Forum captivated at China Medical City, will deepen Beike's administration in accouterment safe, effective, and cutting-edge axis corpuscle treatments to patients from all over the world. The eight organizations that will allotment resources, analysis information, and best practices with Beike Biotech are: AELCELL of Stanford, California, Nanjing Medical University, the China Medical City, Hua Zhong Technical University, the University of Texas Health Science Center at Houston, Jiangsu People's Hospital, the No. 2 Hospital of Nanjing Medical University, and the Wu Hu City No. 2 People's Hospital in Anhui, China. These alternate cooperation agreements awfully access Beike's adeptness to absorb real-time analysis advice into its network, bolstering Beike's position as the Asian baton and one of the world's foremost biotechnology companies accouterment axis corpuscle solutions for a ambit of ailments.
Dr. Sean Hu, the Chairman of Beike Biotech, stated, "Beike realizes there is absolutely backbone in numbers if it comes to advertent the latest and best axis corpuscle technologies that will bigger action a ambit of abhorrent diseases. Therefore, we are acutely agog to be allied with eight of the world's arch axis corpuscle analysis centers, so that calm we can added rapidly accompany able treatments to those who charge it today."
On the sidelines of the Forum, Beike aswell approved out a amount of awful admired doctors from China and abroad to serve on a anew accustomed "Data and Safety Monitoring Board (DSMB)" that will baby-sit Beike-sponsored axis corpuscle research. The DSMB, which is Chaired by Dr. Li Zhanquan of China's Liaoning People's Hospital and includes Dr. Geng Yongjian of the University of Texas Medical School, will accomplish in band with the alcohol of the Declaration of Helsinki, the Council of International Organizations of Medical Sciences (CIOMS), International Ethical Guidelines for Biomedical Research Involving Human Subjects, and Guidelines for Good Clinical Practice from the World Health Organization (WHO) and The International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Members of the DSMB will analysis abstracts protocols and accomplish stringent, all-embracing assurance standards for specific analytic trials Beike affairs to conduct this year.
Additionally, a "Stem Cell Expert Advisory Committee" was accustomed from a allotment of China's top science institutions to accommodate admonition to Beike on ethical issues accoutrement basal and analytic axis corpuscle research, as able-bodied analyze analytic balloon activity teams for complete abstracts ecology and best assurance practices. The 5 alternating Members of the Stem Cell Expert Advisory Committee, which initially cover Dr. Wang Zhonggao of the celebrated Chinese Academy of Sciences and Dr. Chen Hao Zhu of the China Engineering Academy, will accommodate advice on ethical issues and analyze analytic trials for assurance monitoring, aswell adhering to all all-embracing protocols declared aloft such as Helsinki, CIOMS, WHO, and ICH.
Dr. Sean Hu added said, "We at Beike are committed to accouterment accuracy and resonance in the anew advance axis corpuscle analysis and analysis fields. We seek to set the all-around standard, demonstrating that aggregate we do is genuine, safe, and of world-class quality. This is why we will abide to access transparency, affable all-embracing accepted blank systems which will serve to accomplish the Beike aggregation and our casework even better."
About Beike Biotechnology Company Limited
Beike is a biotechnology aggregation founded in July 2005 with basic from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall. That year it commercialized axis corpuscle technology that had been in analysis back 1999. The analysis and analytic plan comes from collaborations with arch institutions in China including Tsinghua University, Beijing University, Hong Kong University of Science and Technology, No. 3 Army Medical University, Zhongshan Medical University, Guiyang Medical College and Zhengzhou University. Over 250 patients anniversary ages are advised with Beike's axis beef in arch hospitals throughout China. Patient adventures from treatments can be begin at Stem Cell China News ( http://www.stemcellschina.com ).
SOURCE: Beike Biotech Company, Ltd.
CONTACT: Shirley Li, Beike Biotech Company, Ltd., Shenzhen Hi-Tech Industrial Park at +86-755-2673-7020 or info@beikebiotech.com
Web site: http://www.beikebiotech.com http://www.stemcellschina.com
CO: Beike Biotechnology Company Limited
ST: China
IN: HEA BIO MTC
SU: JVN
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment